Wed, Apr 26, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRX Indices reports hedge funds returned positive gains in each month of the third quarter

Thursday, October 04, 2012
Opalesque Industry Updates - HFRX reports that equities posted gains in September to conclude the 3rd quarter, though gains were pared into month end on renewed European sovereign debt concerns despite stimulus measures by US, European and Japanese central banks. Equity gains were led by Cyclicals, Financials and Commodity sensitive sectors, with regional leadership from Asian and Emerging Markets.

US Treasury yields rose for the month but settled off mid-month highs as the long end of the curve steepened and high yield credit tightened for the month. The Euro settled with monthly gains against the US dollar, with these also pared into month end; the Pound posted similar gains while the Dollar strengthened against the Japanese Yen. Energies and Precious Metal Commodities diverged for the month with losses in Oil and gains across Aluminum and Silver; Natural Gas also posted a sharp increase. Hedge funds were positive in each month of 3rd quarter, with the HFRX Global Hedge Fund Index gaining +0.39% for September, the 3rd consecutive month of gains. The HFRX Market Directional Index gained +0.98%, also posting its 3rd consecutive month of gains.

The HFRX Equity Hedge Index posted a gain of +0.78 for September, the 4th consecutive month of gains, as equity markets rose across most sectors and regions, and positive contributions across Value, Growth, Energy, Technology and Emerging Markets exposures. The HFRX Fundamental Value Index gained +0.83%, with contributions from Consumer, Industrial, Financials and European equities. The HFRX Fundamental Growth Index posted a gain of +0.71% with contributions from Consumer, Telecom, Asian, Emerging Markets and US small cap exposures. The HFRX Market Neutral Index posted a decline of -0.28% for the month, with weakness in trading oriented EMN strategies.

The HFRX Event Driven Index posted a gain of +0.67% for September, the 3rd consecutive month of gains, with contributions from Equity Special Situations, Distressed and Activist strategies only partially offset by weakness in Arbitrage exposure. The HFRX Special Situations Index posted a gain +0.89%, with positive contributions across both equity and credit sensitive exposures; the HFRX Distressed Index posted a smaller gain of +0.30% on idiosyncratic credit improvement. The HFRX Merger Arbitrage Index posted a decline of -0.26% on mixed contributions from core positions in Hertz/Dollar Thrifty, Glencore/Xstrata, Duke Energy/Progress Energy and exposure to the Consumer and Technology sectors.

The HFRX Relative Value Arbitrage Index posted a gain of +0.43% for September, with contributions from Multi-Strategy, Corporate Fixed Income and MLP strategies. The HFRX MLP Index gained +1.94% on continued strong demand across energy infrastructure, transport and storage positions. Credit and commodity tightening again offset rising treasury yields, contributing to a gain of +0.27% for the HFRX RV: Multi-Strategy Index. The HFRX Convertible Arbitrage Index posted a decline of -0.26% as rising yields and falling volatility offset credit gains.

The HFRX Macro CTA Index posted a decline of -0.52% for the period, as weakness in Systematic Macro offset gains in Discretionary Commodity and Fixed Income exposures. The HFRX Systematic Diversified CTA Index posted a decline of -1.75% for the month, with weakness as a function of intra-month reversals in various commodity and equity positions, across both medium to long term trending strategies.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V